J. Melville Engle, Director at Predictive Oncology Inc. (POAI), bought 159,500 shares at $0.37 ($59K) on 2022-05-24, disclosed to the SEC on 2022-05-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| KOOL | BUY | 2009-05-12 | $55K | — | Filing → |